TNF-α promotes Doxorubicin-induced cell apoptosis and anti-cancer effect through downregulation of p21 in p53-deficient tumor cells

Biochemical and Biophysical Research Communications

Volumn 330, Issue 4, 2005, Pages 1034-1040

  Cao, Wei ^a   Chi, Wan Hao ^a   Wang, Jun ^b   Tang, Juan Juan ^b   Lu, Yan Jun ^b  

^a FUDAN UNIVERSITY   (China)

^b Cancer Research Center   (China)

Author keywords

CDK2; NF B RelA p65; p21; p53; TNF

Indexed keywords

CYCLIN DEPENDENT KINASE 2; DOXORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P21; PROTEIN P53; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 17044393896     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.02.188     Document Type: Article

References (36)

1. A.H. van Der Veen, T.L.M. ten Hagen, J.H.W. de Wilt, M.G.A. van Ijken, and A.M.M. eggermont An overview on the use of TNF-alpha: our experience with regional administration and developments towards new opportunities for systemic application Anticancer Res. 20 2000 3467 3474
2. S.T. Whiteside, M.K. Ernst, O. Lebail, C. Laurent-Winter, N. Rice, and A.A. Israel N- and C-terminal sequences control degradation of MAD3/I kappa B alpha in response to inducers of NF-kappa B activity Mol. Cell. Biol. 15 1995 5339 5345
3. M.L. Sherman, D.R. Spriggs, K.A. Arthur, K. Imamura, E. Frei III, and D.W. Kufe Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism J. Clin. Oncol. 6 1988 344 350
4. D.R. Spriggs, M.L. Sherman, H. Michie, K.A. Arthur, K. Imamura, D. Wilmore, E. Frei III, D.W. Kufe, and D.W. Kufe Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion: a phase I and pharmacologic study J. Natl. Cancer Inst. 80 1988 1039 1044
5. R. Kamijo, K. Takeda, M. Nagumo, K. Konno, A. Hasegawa, K. Inaka, and M. Ikehara Induction of differentiation of human monoblastic and myeloblastic leukemia cell lines by TNF muteins Biochem. Biophys. Res. Commun. 160 1989 820 827
6. S. Nakamura, A. Kato, T. Masegi, M. Fukuoka, K. Kita, H. Ogawa, Y. Ichikaw, M. Maeda, N. Watanabe, Y. Kohgo, and Y. Niitsu A novel recombinant tumor necrosis factor-alpha mutant with increased anti-tumor activity and lower toxicity Int. J. Cancer. 48 1991 744 748
7. Q.H. Zhou, M. Hou, L. Li, L. Ren, M. Qiu, Y.Q. Yang, W.X. Huang, Z. Hen, Z.Q. Meng, M.Z. Song, M.Z. Li, E.X. Li, Y. Li, Y. Yao, Z.E. Zheng, X. Liu, X.F. Zhang, H.S. Lu, M.H. Zhang, X.W. Wang, and X.J. Yu A multicenter randomized phase II trial of domestic product of nrh-TNF in the treatment of non-small cell lung cancer Chin. J. Lung Cancer 6 2003 42 45
8. Z. Chen, L.M. Liu, and W.X. Huang A clinical research on rnhTNF for 87 cases with advanced cancer Chin. J. Clin. Oncol. 30 2003 877 880
9. E.X. Li, M.Z. Li, and K.J. NAN Randomized-controlled study of recombinant mutant human tumor necrosis factor in advanced malignant tumor Chin. Oncol. 13 2003 353 355
10. Y.J. Lu, M. Tatsuka, H. Takebe, and T. Yagi Involvement of cyclin-dependent kinases in doxorubicin-induced apoptosis in human tumor cells Mol. Carcinogen. 29 2000 1 7
11. Y.J. Lu, N. Yamagishi, T. Yagi, and H. Takebe Mutated p21(WAF1/CIP1/SDI1) lacking CDK-inhibitory activity fails to prevent apoptosis in human colorectal carcinoma cells Oncogene 16 1998 705 712
12. T. Waldman, C. Lengauer, K.W. Kinzler, and B. Vogelstein Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21 Nature 381 1996 713 716
13. K. Nakano, and K.H. Vousden PUMA, a novel proapoptotic gene, is induced by p53 Mol. Cell 7 2001 683 694
14. L. Zhang, J. Yu, B.H. Park, K.W. Kinzler, and B. Vogelstein Role of BAX in the apoptotic response to anticancer agents Science 290 2000 989 992
15. G.S. Wu, and Z.H. Ding Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line Oncogene 21 2000 1 8
16. T. Ando, T. Kawabe, H. Ohara, B. Ducommun, M. Itoh, and T. Okamoto Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2/M arrest after DNA damage J. Biol. Chem. 276 2001 42971 42977
17. K.Y. Lee, W.T. Chang, D.M. Qiu, P.N. Kao, and G.D. Rosen PG490 (triptolide) cooperates with tumor necrosis factor-alpha to induce apoptosis in tumor cells J. Biol. Chem. 274 1999 13451 13455
18. B. Lin, C. Williams-Skipp, Y. Tao, M.S. Schleicher, L.L. Cano, R.C. Duke, and R.I. Scheinman NF-kappaB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type Cell Death Differ. 6 1999 570 582
19. L.D. Attardi, E.E. Reczek, C. Cosmas, E.G. Demicco, M.E. McCurrach, S.W. Lowe, and T. Jacks PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family Genes Dev. 14 2000 704 718
20. M.S. Soengas, R.M. Alarcon, H. Yoshid, A.J. Giaccia, R. Hakem, T.W. Mak, and S.W. Lowe Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition Science 284 1999 156 159
21. T. Miyashita, and J.C. Reed Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Cell 80 1995 293 299
22. L.B. Owen-Schaub, W. Zhang, J.C. Cusack, L.S. Angelo, S.M. Santee, T. Fujiwara, J.A. Roth, A.B. Deisseroth, W.W. Zhang, and E. Kruzel Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression Mol. Cell. Biol. 15 1995 3032 3040
23. G.S. Wu, T.F. Burns, E.R. McDonald III, W. Jiang, R. Meng, I.D. Krantz, G. Kao, D.D. Gan, J.Y. Zhou, R. Muschel, S.R. Hamilton, N.B. Spinner, S. Markowitz, G. Wu, and W.S. el-Deiry KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene Nat. Genet. 17 1997 141 143
24. K. Oda, H. Arakawa, T. Tanaka, K. Matsuda, C. Tanikawa, T. Mori, H. Nishimori, K. Tamai, T. Tokino, Y. Nakamura, and Y. Taya p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53 Cell 102 2000 849 862
25. S. Benchimol p53-dependent pathways of apoptosis Cell Death Differ. 8 2001 1049 1051
26. J.L. Yu, J.W. Rak, B.L. Coomber, D.J. Hicklin, and R.S. Kerbel Effect of p53 status on tumor response to antiangiogenic therapy Science 295 2002 1526 1528
27. M. Ameyar-Zazoua, N. Larochette, G. Dorothee, E. Daugas, H. Haddada, and V. Gouloumet Wild-type p53 induced sensitization of mutant p53 TNF-resistant cells: role of caspase-8 and mitochondria Cancer Gene Ther. 9 2002 219 227
28. A. Phillps, M. Ernst, S. Bates, N. Rice, and K. Vousden E2F-1potentiates cell death by blocking antiapoptotic signaling pathways Mol. Cell 4 1999 771 781
29. C. Gomez-Manzano, J. Fueyo, F. Alamaeda, A.P. Kyritsis, and W.K. Yung Gene therapy for gliomas: p53 and E2F-1 proteins and the target of apoptosis Int. J. Mol. Med. 3 1999 81 85
30. T.M. Guadagno, and J.W. Newport Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity Cell 84 1996 73 82
31. J. Rosenblatt, Y. Gu, and D.O. Morgan Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A Proc. Natl. Acad. Sci. USA 89 1992 2824 2828
32. J. Kawauchi, C. Zhang, K. Nobori, Y. Hashimoto, M.T. Adachi, A. Noda, M. Sunamori, and S. Kitajima Transcriptional repressor activating transcription factor 3 protects human umbilical vein endothelial cells from tumor necrosis-α-induced apoptosis though down-regulation of p53 transcription J. Biol. Chem. 277 2002 39025 39034
33. K.M. Ryan, M.K. Emst, N.R. Rice, and K.H. Vousden Role of NFκB in p53-mediated programmed cell death Nature 404 2000 892 949
34. M.P. Boland, K.A. Fitzgerald, and L.A.J. O'Neill Topoisomerase II is required for mitoxantrone to signal nuclear factor κB activation in HL60 cells J. Biol. Chem. 275 2000 25231 25238
35. M. Bendjennat, J. Boulaire, T. Jascur, H. Brickner, V. Barbier, A. Sarasin, A. Fotedar, and R. Fotedar UV irradiation triggers ubiquitin-dependent degradation of p21(WAF1) to promote DNA repair Cell 114 5 2003 599 610
36. N.D. Perkins, L.K. Felzien, J.C. Betts, K. Leung, D.H. Beach, and G.J. Nabel Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator Science 275 1997 523 527